Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 OCF Margin % is 32.88% as of Mar. 2026, which is 5% below its 10-year median of 34.79. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 815 Medical Devices & Instruments companies, Kitazato ranks better than 95.95% on this metric.
The historical rank and industry rank for Kitazato's OCF Margin % or its related term are showing as below:
TSE:368A'
s OCF Margin % Range Over the Past 10 Years
Min: 22.79 Med: 34.79 Max: 44.64
Current: 35.35
During the past 4 years, the highest OCF Margin % of Kitazato was 44.64%. The lowest was 22.79%. And the median was 34.79%.
TSE:368A's OCF Margin % is ranked better than 95.95% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.75
vs TSE:368A: 35.35
The historical data trend for Kitazato's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:368A vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Kitazato's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Kitazato's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kitazato (TSE:368A) has a OCF Margin % of 32.88% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kitazato and its competitors. This is near median its historical median of 34.79. Over the past decade, Kitazato's OCF Margin % has ranged from 22.79 to 44.64. According to the industry distribution chart, Kitazato ranks #33 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is Kitazato's OCF Margin % too high?
Kitazato's current OCF Margin % of 32.88% is near median its 10-year median of 34.79. Over the past 10 years, this metric has ranged from a low of 22.79 to a high of 44.64. The Medical Devices & Instruments industry median OCF Margin % is 5.75. Kitazato's value of 32.88% is 471.8% above this industry median. Based on the distribution chart, Kitazato ranks #33 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #33 out of 815 companies for OCF Margin %. This places Kitazato in the top 4% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.75. Kitazato's value of 32.88% is 471.8% above this benchmark. Historically, Kitazato's own OCF Margin % has ranged from 22.79 to 44.64 over the past decade. While the company's 10-year median is 34.79 vs. the industry median of 5.75, Kitazato has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kitazato's current OCF Margin % of 32.88% is 471.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kitazato and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kitazato's current OCF Margin % is 32.88%, which is near median its own 10-year median of 34.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current OCF Margin % of 32.88%. The current OCF Margin % is 32.88%, which is near median its 10-year median of 34.79 and 471.8% above the Medical Devices & Instruments industry median of 5.75. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Kitazato (TSE:368A), the current OCF Margin % is 32.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
